This document discusses change control in the pharmaceutical industry. It begins by defining change control as a formal system to review proposed or actual changes that could affect facilities, systems, equipment, or processes. The functions of change control are then outlined as identifying, reviewing, approving, validating, analyzing, and monitoring changes. The areas of change that would require control are described, including manufacturing, quality control, research and development, engineering, and marketing. Finally, the document states that written procedures and documentation like standard operating procedures and change control forms are necessary parts of the change control system.
WHO Good Manufacturing Practice Requirements
Good Manufacturing Practice is the part of quality assurance that ensures that products are consistently manufactured and controlled to the quality standards appropriate to their intended use.
WHO Good Manufacturing Practice Requirements
Good Manufacturing Practice is the part of quality assurance that ensures that products are consistently manufactured and controlled to the quality standards appropriate to their intended use.
PIC/S is a combine term used for the execution of activities of Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme
harmonize, educate, and update aspects relating to Good Manufacturing Practice among member countries
harmonized relation among regulatory authorities and governments
members
history
role
objective and function
guidlines
A Study on Documentation Maintenance in the Pharmaceutical Industry which includes the main records to be maintained and the quality attributes to be studied about the Quality Management System. Quality attributes include the study of quality audit, quality review, and quality documentation.
It is process of “Establishing documentary evidence that provide a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes”.
In the pharmaceutical industry, it is very important that in addition to final testing and compliance of products, it is also assured that the process will consistently produce the expected results.
Validation is action of proving in accordance with the principles of good manufacturing practices, that any procedure, process, equipment, material, activity or system actually leads to expected results.
Cleaning validation is documented evidence with a high degree assurance that one can consistently clean a system or a piece of equipment to predetermined and acceptable limits.
The primary regulatory concern driving the need for cleaning validation is cross contamination of the desired drug substance either by other API from previous batch runs or by residues from the cleaning agents used.
The prime purpose of validating a cleaning process is to ensure compliance with federal and other standard regulations
1. Cross contamination with active ingredients
Contamination of one batch of product with significant levels of residual active ingredients from previous batch cannot be tolerated.
In addition to the obvious problems posed by subjecting consumers or patients to unintended contaminants, potential clinically significant synergistic interactions between pharmacologically active chemicals are a real concern.
2. Contamination with unintended materials or compounds
While inert ingredients used in drug products are generally recognized as safe for human consumption, the routine use, maintenance and cleaning of equipment's provide the potential contamination with such items as equipment parts, lubricants and chemical cleaning agents3. Microbiological contamination
Maintenance , cleaning and storage conditions may provide adventitious microorganisms with the opportunity to proliferate within the processing equipment.
Regulatory aspect of pharmaceutical change control systemDeveshDRA
CHANGE CONTROL,BENEFITS OF CHANGE CONTROL SYSTEM,MANAGEMENT OF CHANGE AND CONTINUOUS IMPROVEMENT(Prepare a Change Proposal,Classify & Approve Proposed Changes,Develop an Implementation Plan, Install the Change,Verify Installation,Close out the change
) FLOW CHART OF CHANGE MANAGEMENT,HANDLING AND CONTROLLING CHANGES,SOP ON CHANGE CONTROL SYSTEM,
CATEGORY OF CHANGES(Major Changes,Moderate changes,Minor changes),ENSURING TRAINING & PROCEDURES IN A MANAGEMENT OF CHANGE PROGRAM,LEVEL OF APPROVAL,REGULATOR PROSPECTIVE OF CHANGE CONTROL(21 CFR Part 211: Sec. 211.100,21 CFR Part 211.194 (Laboratory Records),ICH Q7A,USFDA Guidance for Industry: Change to an approved NDA or ANDA ( April 2004- Revison-1)),CONCLUSION
,
PIC/S is a combine term used for the execution of activities of Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme
harmonize, educate, and update aspects relating to Good Manufacturing Practice among member countries
harmonized relation among regulatory authorities and governments
members
history
role
objective and function
guidlines
A Study on Documentation Maintenance in the Pharmaceutical Industry which includes the main records to be maintained and the quality attributes to be studied about the Quality Management System. Quality attributes include the study of quality audit, quality review, and quality documentation.
It is process of “Establishing documentary evidence that provide a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes”.
In the pharmaceutical industry, it is very important that in addition to final testing and compliance of products, it is also assured that the process will consistently produce the expected results.
Validation is action of proving in accordance with the principles of good manufacturing practices, that any procedure, process, equipment, material, activity or system actually leads to expected results.
Cleaning validation is documented evidence with a high degree assurance that one can consistently clean a system or a piece of equipment to predetermined and acceptable limits.
The primary regulatory concern driving the need for cleaning validation is cross contamination of the desired drug substance either by other API from previous batch runs or by residues from the cleaning agents used.
The prime purpose of validating a cleaning process is to ensure compliance with federal and other standard regulations
1. Cross contamination with active ingredients
Contamination of one batch of product with significant levels of residual active ingredients from previous batch cannot be tolerated.
In addition to the obvious problems posed by subjecting consumers or patients to unintended contaminants, potential clinically significant synergistic interactions between pharmacologically active chemicals are a real concern.
2. Contamination with unintended materials or compounds
While inert ingredients used in drug products are generally recognized as safe for human consumption, the routine use, maintenance and cleaning of equipment's provide the potential contamination with such items as equipment parts, lubricants and chemical cleaning agents3. Microbiological contamination
Maintenance , cleaning and storage conditions may provide adventitious microorganisms with the opportunity to proliferate within the processing equipment.
Regulatory aspect of pharmaceutical change control systemDeveshDRA
CHANGE CONTROL,BENEFITS OF CHANGE CONTROL SYSTEM,MANAGEMENT OF CHANGE AND CONTINUOUS IMPROVEMENT(Prepare a Change Proposal,Classify & Approve Proposed Changes,Develop an Implementation Plan, Install the Change,Verify Installation,Close out the change
) FLOW CHART OF CHANGE MANAGEMENT,HANDLING AND CONTROLLING CHANGES,SOP ON CHANGE CONTROL SYSTEM,
CATEGORY OF CHANGES(Major Changes,Moderate changes,Minor changes),ENSURING TRAINING & PROCEDURES IN A MANAGEMENT OF CHANGE PROGRAM,LEVEL OF APPROVAL,REGULATOR PROSPECTIVE OF CHANGE CONTROL(21 CFR Part 211: Sec. 211.100,21 CFR Part 211.194 (Laboratory Records),ICH Q7A,USFDA Guidance for Industry: Change to an approved NDA or ANDA ( April 2004- Revison-1)),CONCLUSION
,
Specific Detailed Changes to the New ISO 13485:2016Greenlight Guru
Today's medical device regulatory environment is changing faster than ever. Keeping up can be daunting. The new quality management standard ISO 13485:2016 was published in Q1 of 2016.
greenlight.guru has partnered with special guest and consultant, Mark Swanson, to keep you ahead of these changes.
Mark spent the last 4 years on the working group that revised the new ISO 13485.
Mark has all the exclusive insider knowledge on the changes you want. And he's going to be sharing it with you for free.
(You can view the full webinar here: http://www.greenlight.guru/webinar/iso-13485-2016-changes)
In this webinar you'll learn specifically:
-How to prepare for the coming regulatory changes with ISO 13485:2016
-How to apply risk based thinking to your quality processes to ensure compliance
-What you need to know about the design control updates
-How to incorporate ISO 9001:2015 and 13485:2016 to your supplier controls
-A general overview of the standard and its most significant changes (before anyone else)
Validation.
Validation is establishing documented evidence which provides a high degree of assurances that a specific process or equipment will consistently produce a product or result meeting its predetermined specifications and quality attributes”.
A system must be qualified to operate in a validated process
The results of analytical procedures should be:
— reliable
— accurate
— reproducible
The characteristics that should be considered during validation of analytical methods are:
— specificity
— linearity
— range
— accuracy
— precision
— detection limit
— quantitation limit
— robustness
Complete discussion about the Pharmaceutical validation, its types, difference between calibration and validation, validation master & calibration master plan
This is a presentation based on ICH Q10, Pharmaceutical Quality System, It was shared recently with participants of a training session arranged by Ingrope Information Services karachi at marriot Hotel. I am uploading for the benefits of all pharma colleagues, specially the junior ones.
Similar to QUALITY MANAGEMNT SYSTEMS: Change Control (CC) (20)
Nonlinear Pharmacokinetics
-Tests to detect nonlinearity in pharmacokinetics
-CAUSES OF NONLINEARITY
-MICHAELIS MENTEN EQUATION
-Estimation of Km and V max
-Km and V max from Steady State Concentration
Multiple Dosage Regimens
1. Define the index for measuring drug accumulation.
2. Define drug accumulation and drug accumulation t1/2
3. Explain the principle of superposition and its assumptions in multiple dose regimens.
4. Describe Repetitive Intravenous injections One Compartment Open Model
5. Describe Repetitive Extravascular dosing One Compartment Open model
6. Describe Multiple Dose Regimen Two Compartment Open Model
Non compartmental pharmacokinetics & physiologic pharmacokinetic models by aktDr Ajay Kumar Tiwari
Non Compartmental Analysis
-Assumptions to be made
-Statistical Moment Theory
-Mean Residence Time
-Mean Transit Time (MTT), Mean Absorption Time (MAT), and Mean Dissolution Time (MDT)
-Other Pharmacokinetic Parameters
-Advantages and Disadvantages of Noncompartmental Versus Compartmental Population Analyses
Physiologic Pharmacokinetic Models
-Physiologically based pharmacokinetic (PBPK) modeling
-Assumption to be made
-advantages & disadvantage
MULTICOMPARTMENT MODELS
TWO COMPARTMENT OPEN MODEL
-Intravenous Bolus Administration
-Intravenous Infusion
-Extravascular administration
-method of residuals
-Urinary excretion data
-Loo Riegelman method
One-compartment open model
1.One compartment open model intravenous bolus administration.
2.One compartment open model continuous intravenous infusion .
3.One compartment open model extravascular zero order absorption .
4.One compartment open model extravascular first order absorption
1.Definition and introduction to Pharmacokinetics.
2.Basic considerations in Pharmacokinetics.
3.Pharmacokinetic models.
4.Compartment models.
5.Pharmacokinetics parameters
Qms NATIONAL ACCREDITATION BOARD FOR TESTING AND CALIBRATION LABORATORIES (...Dr Ajay Kumar Tiwari
Fundamental knowledge on pharmaceutical
product development and translation from laboratory to market.
Quality management systems: Quality management & Certifications.
1. Introduction to NABL
2. NABL and ISO Principles
3. Need of NABL
4. Recognition of NABL in International Level
5. Scope of NABL
6. Advantages of NABL
quality management systems: Total quality management & Quality by designDr Ajay Kumar Tiwari
Fundamental knowledge on pharmaceutical
product development and translation from laboratory to market.
Quality management systems: Quality management & Certifications.
Total quality management
Quality by design
Fundamental knowledge on pharmaceutical
product development and translation from laboratory to market.
Quality management systems: Quality management & Certifications.
Introduction to OOS
Identification of OOS: Reports of Laboratory Investigation
Responsibility of Analyst and Supervisor
Identification of OOS:
Reports of Full Scale Investigation
Review of Manufacturing, Production and Sampling
Review of Lab Investigation Result
Supplementary Laboratory Testing Procedure
Analysis of Investigated Results
Fundamental knowledge on pharmaceutical
product development and translation from laboratory to market.
Quality management systems: Quality management & Certifications.
Si x sigma concepts.
Aim of 6 sigma concepts.
Process of 6 sigma concepts.
Fundamental knowledge on pharmaceutical
product development and translation from laboratory to market.
Quality management systems: Quality management & Certifications.
ISO Quality Standards
1. Quality Management System (QMS)
2. ISO Quality Standards
3. ISO 9000
4. ISO 9000 Series
5. Requirements of ISO 9000 Series
6. Advantages of ISO Certification
Fundamental knowledge on pharmaceutical
product development and translation from laboratory to market.
Quality management systems: Quality management & Certifications.
ISO Quality Standards
1. Introduction to ISO 14000
2. Principle of ISO 14000
3. Features of ISO 14000
4. Advantages of ISO 14000
5. ISO 14000 Series
6. Process of ISO 14001 Certification
7. Environmental Management System (EMS)
8. Features of EMS
Quality management systems: Good Laboratory Practice (QMS GLP)Dr Ajay Kumar Tiwari
Fundamental knowledge on pharmaceutical
product development and translation from laboratory to market.
Quality management systems: Quality management & Certifications.
1. Introduction to GLP
2. Definition of GLP
3. Fundamentals of GLP
4. GLP Principles
5. Aim of GLP
Synthetic Fiber Construction in lab .pptxPavel ( NSTU)
Synthetic fiber production is a fascinating and complex field that blends chemistry, engineering, and environmental science. By understanding these aspects, students can gain a comprehensive view of synthetic fiber production, its impact on society and the environment, and the potential for future innovations. Synthetic fibers play a crucial role in modern society, impacting various aspects of daily life, industry, and the environment. ynthetic fibers are integral to modern life, offering a range of benefits from cost-effectiveness and versatility to innovative applications and performance characteristics. While they pose environmental challenges, ongoing research and development aim to create more sustainable and eco-friendly alternatives. Understanding the importance of synthetic fibers helps in appreciating their role in the economy, industry, and daily life, while also emphasizing the need for sustainable practices and innovation.
2024.06.01 Introducing a competency framework for languag learning materials ...Sandy Millin
http://sandymillin.wordpress.com/iateflwebinar2024
Published classroom materials form the basis of syllabuses, drive teacher professional development, and have a potentially huge influence on learners, teachers and education systems. All teachers also create their own materials, whether a few sentences on a blackboard, a highly-structured fully-realised online course, or anything in between. Despite this, the knowledge and skills needed to create effective language learning materials are rarely part of teacher training, and are mostly learnt by trial and error.
Knowledge and skills frameworks, generally called competency frameworks, for ELT teachers, trainers and managers have existed for a few years now. However, until I created one for my MA dissertation, there wasn’t one drawing together what we need to know and do to be able to effectively produce language learning materials.
This webinar will introduce you to my framework, highlighting the key competencies I identified from my research. It will also show how anybody involved in language teaching (any language, not just English!), teacher training, managing schools or developing language learning materials can benefit from using the framework.
The Art Pastor's Guide to Sabbath | Steve ThomasonSteve Thomason
What is the purpose of the Sabbath Law in the Torah. It is interesting to compare how the context of the law shifts from Exodus to Deuteronomy. Who gets to rest, and why?
We all have good and bad thoughts from time to time and situation to situation. We are bombarded daily with spiraling thoughts(both negative and positive) creating all-consuming feel , making us difficult to manage with associated suffering. Good thoughts are like our Mob Signal (Positive thought) amidst noise(negative thought) in the atmosphere. Negative thoughts like noise outweigh positive thoughts. These thoughts often create unwanted confusion, trouble, stress and frustration in our mind as well as chaos in our physical world. Negative thoughts are also known as “distorted thinking”.
Palestine last event orientationfvgnh .pptxRaedMohamed3
An EFL lesson about the current events in Palestine. It is intended to be for intermediate students who wish to increase their listening skills through a short lesson in power point.
Unit 8 - Information and Communication Technology (Paper I).pdfThiyagu K
This slides describes the basic concepts of ICT, basics of Email, Emerging Technology and Digital Initiatives in Education. This presentations aligns with the UGC Paper I syllabus.
Ethnobotany and Ethnopharmacology:
Ethnobotany in herbal drug evaluation,
Impact of Ethnobotany in traditional medicine,
New development in herbals,
Bio-prospecting tools for drug discovery,
Role of Ethnopharmacology in drug evaluation,
Reverse Pharmacology.
How to Create Map Views in the Odoo 17 ERPCeline George
The map views are useful for providing a geographical representation of data. They allow users to visualize and analyze the data in a more intuitive manner.
How to Make a Field invisible in Odoo 17Celine George
It is possible to hide or invisible some fields in odoo. Commonly using “invisible” attribute in the field definition to invisible the fields. This slide will show how to make a field invisible in odoo 17.
5. TREY
research
5
CHANGE CONTROL
In pharmaceutical industry
change control is an important part of quality assurance.
The changes proposed and made in any procedure or
process should be
reviewed, established, documented and approved by
the concerned authorities.
Change control is the system
to implement this approved change
to confirm the regulatory requirements.
6. TREY
research
6
CHANGE CONTROL:
Definition
Change control can be defined as;
“A formal system by which qualified representatives of
appropriate disciplines review proposed or actual changes
that might affect the validated status of -
facilities,
systems,
equipment or
processes.
The intent is to determine the need for action that would
ensure and document that the system is maintained in a
validated state”.
(EU GMP Guidelines, Annexure 15)
7. TREY
research
7
CHANGE CONTROL:
Function
Any change in manufacturing process, equipment, materials
used that may cause alteration in product quality should be
validated.
The main functions of change control are:
1. Identification of the changes made.
2. Review of the change.
3. Approval of the change.
4. Validating the changes which can alter the product quality,
regulatory or GMP requirements.
5. Analysis of the change and monitoring of the impact of
change.
8. TREY
research
8
CHANGE CONTROL:
Area of Change
1. Manufacture:
Following changes are concerned:
• Raw materials
• Equipments
• Process/parameters
• Testing/validation procedures
• Packaging materials
• Cleaning process
9. TREY
research
9
CHANGE CONTROL:
Area of Change
2. Quality control and quality assurance:
Following changes are considered:
• Quality testing parameters
• Sampling size
• Validation process
• Specifications of
raw materials, intermediates and final product
• Documentation
• Standard operating procedures (SOPs)
10. TREY
research
10
CHANGE CONTROL:
Area of Change
3. Research and development:
It includes the change in;
• Manufacturing process
(any addition OR elimination of steps)
• Raw materials
(any addition OR omission of the product)
• Specifications of
raw materials, intermediates and final product
• Quantitative aspects of
raw materials and finished products
• Manufacturing conditions and storage conditions
• Testing/validation procedures
11. TREY
research
11
CHANGE CONTROL:
Area of Change
4. Engineering:
It includes the following changes in:
• Equipment used
• Validation of the equipment
• Parts of equipment
• Working and design layout
• Software/ Hardware or Change in any program
5. Marketing.
12. TREY
research
12
CHANGE CONTROL:
Written Procedures and
Documentation
Procedures in writing
should be kept at the proper place
to describe the changes made related to
the materials, equipment and
method of manufacturing or testing conditions or
any other change that can affect the quality of the
product.
Standard operating procedure (SOP) and records of
change control documents are required for the
documentation.
13. TREY
research
13
CHANGE CONTROL:
Written Procedures and
Documentation
Change Control Form (CCF)
is an important documentation part of change control.
It contains the form related to initiate department for
the proposed change,
proposed change details,
comments from QA Head, category of the changes,
supportive documents,
management review form and
assessment of CCF.
16. B.PHARM. VII-SEMESTER BP 702 T. INDUSTRIAL PHARMACY-II (Theory)
DR. AJAY K. TIWARI, ASSOCIATE PROFESSOR
MAHARISHI ARVIND COLLEGE OF PHARMACY, JAIPUR (RAJ.)
AJAY81AJAY@GMAIL.COM WHATSAPP: 9782226444
Tobecontinued...